CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 77 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-28 | Lebovits Chaim See Remarks | Grant or award · Stock Option (right to buy) | +369,619 | 369,619 | ||
| 2015-09-28 | Lebovits Chaim See Remarks | Grant or award · Stock Option (right to buy) | +369,619 | 369,619 | ||
| 2015-08-27 | SHORR ROBERT G L Director | Grant or award | +8,666 | 49,999 | ||
| 2015-08-27 | TAUB MALCOLM S Director | Grant or award | +8,666 | 50,554 | ||
| 2015-08-27 | Yablonka Uri Chief Operating Officer | Grant or award · Stock Option (right to buy) | +13,333 | 13,333 | ||
| 2015-08-27 | Pinkas Alon Director | Grant or award · Stock Option (right to buy) | +15,333 | 15,333 | ||
| 2015-08-27 | Friedman Mordechai Director | Grant or award · Stock Option (right to buy) | +16,666 | 16,666 | ||
| 2015-08-27 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2015-08-20 | Bibring Yoram Chief Financial Officer | Purchase | +8,500 | $3.04 | $26K | 50,000 |
| 2015-08-17 | Bibring Yoram Chief Financial Officer | Purchase | +41,500 | $2.92 | $121K | 41,500 |
| 2015-07-30 | Bibring Yoram Chief Financial Officer | Grant or award · Stock Option (right to buy) | +165,000 | 165,000 | ||
| 2015-06-01 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2015-05-03 | Schor Chen Director | Grant or award | +60,000 | 121,558 | ||
| 2014-10-15 | Fiorino Anthony S. Chief Executive Officer | Purchase | +200 | $3.59 | $718 | 2,200 |
| 2014-10-15 | Fiorino Anthony S. Chief Executive Officer | Purchase | +300 | $3.60 | $1K | 2,500 |
| 2014-10-10 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +1,000 | $4.29 | $4K | 120,006 |
| 2014-10-10 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +2,500 | $4.09 | $10K | 122,506 |
| 2014-10-10 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +200 | $4.08 | $816 | 122,706 |
| 2014-10-10 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +300 | $4.05 | $1K | 123,006 |
| 2014-10-10 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +600 | $4.04 | $2K | 123,606 |
Page 10 of 14 · 274 trades